Metabolomic profiling reveals distinct lipid signatures in progressive versus stable fibrotic lung diseaseFaizan Faizee, Girish B. Nair, Romana Ashrafi Mimi et al.|Metabolomics|2025Cited by 5
Trilaciclib use for prevention of hematological adverse events in chemotherapy: A meta-analysis of real-world studies and clinical trials.Nitya Batra, Mohammad Muhsin Chisti, Morgan Kiryakoza et al.|Journal of Clinical Oncology|2024Cited by 0
Fibrolamellar hepatocellular carcinoma (FL-HCC) epidemiology, survival characteristics, and outcomes: Surveillance, epidemiology, and end results database (SEER) study.Z. Alnabulsi, Daniel Ezekwudo, Nitya Batra et al.|Journal of Clinical Oncology|2024Cited by 0